The effects of transcranial direct current stimulation on global cognitive function, visuospatial function, and executive function in patients with mild cognitive impairment and Alzheimer’s disease: a meta-analysis

• by Fangzhou Yu, Mingchen Wang

• May 22, 2026

Amyloid-targeting treatment in Alzheimer's disease and concomitant antiplatelets: a clinical gray zone?

• by Rus Prelog, Polona , Zupan, Matija , Kovacic, Alenka , Frol, Senta , Gregoric Kramberger, Milica

• May 4, 2026

This Week’s CGT News: CAR-T Breaks New Ground in Alzheimer’s

First CAR-T approach for Alzheimer’s reduces amyloid plaques in mice, while cell and gene therapies advance across blood cancers, retinal disease, amyloidosis, and FSHD

• May 11, 2026

• 7 min

Biomarkers, Cognitive Function, and Mortality in Centenarians

• by Ryo Shikimoto, Takashi Sasaki, Yukiko Abe, Kenji Tai, Nobuyoshi Hirose, Hideyuki Okano, Yasumichi Arai

• May 7, 2026